Related Experiment Video

Updated: Jun 28, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Myotonic disorders

Ami Mankodi1

  • 1Department of Neurology, Johns Hopkins University, Baltimore, MD 21287, USA. amankod1@jhmi.edu

Neurology India
|November 1, 2008
PubMed

Insights

Myotonic disorders cause muscle hyperexcitability. Myotonic dystrophies involve RNA defects affecting chloride channels, leading to myotonia, while nondystrophic myotonias stem from direct ion channel mutations.

Area of Science:

  • Neurology
  • Molecular Biology
  • Genetics

Background:

  • Myotonia is characterized by muscle fiber hyperexcitability, resulting from impaired chloride or sodium ion conductance.
  • Myotonic disorders are classified into myotonic dystrophies and nondystrophic myotonias.
  • Nondystrophic myotonias are caused by mutations in skeletal muscle chloride (ClC-1) or sodium (SCN4A) channel genes.

Purpose of the Study:

  • To review the clinical presentation of myotonic disorders.
  • To discuss recent advances in understanding the RNA-mediated disease mechanism of myotonic dystrophies.
  • To explore potential therapeutic options for myotonic disorders.

Main Methods:

  • Review of current scientific literature on myotonic disorders.
  • Analysis of genetic and molecular mechanisms underlying myotonic dystrophies.
  • Examination of RNA-mediated pathology involving MBNL1 sequestration and altered ClC-1 splicing.

Main Results:

  • Myotonic dystrophies involve CTG or CCTG repeat expansions in DMPK or ZNF9 genes, respectively.
  • Expanded repeats form nuclear RNA inclusions, sequestering MBNL1 and leading to aberrant ClC-1 mRNA splicing.
  • This process results in non-functional ClC-1 protein and impaired chloride conductance, causing myotonia.

Conclusions:

  • Myotonic dystrophies exhibit a distinct RNA-mediated pathogenesis.
  • Understanding this mechanism is crucial for developing targeted therapies.
  • Further research into RNA-binding proteins and splicing regulation holds therapeutic promise.

More Related Videos

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Myo-mechanical Analysis of Isolated Skeletal Muscle08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Muscle Contraction01:10

Muscle Contraction

In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive muscle...
Muscle Contraction01:15

Muscle Contraction

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...